Effect of Abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - Observations from the TARGET trial
Ivan P. Casserly, Eric J. Topol, Gang Jia, Richard A. Lange, Christian Hamm, Bernhard Meier, Peter M. DiBattiste, Nasser Lakkis, Derek P. Chew, Gregg W. Stone, David J. Cohen, David J. Moliterno
Research output: Contribution to journal › Article › peer-review
9Scopus
citations
Fingerprint
Dive into the research topics of 'Effect of Abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - Observations from the TARGET trial'. Together they form a unique fingerprint.